MIRA INFORM REPORT

 

 

Report Date :

28.10.2014

 

IDENTIFICATION DETAILS

 

Name :

SYNGENE INTERNATIONAL LIMITED (w.e.f. 19.04.2007)

 

 

Formerly Known As :

SYNGENE INTERNATIONAL PRIVATE LIMITED

 

 

Registered Office :

Biocon SEZ, Biocon Park, Plot No. 2/3, Bommansandra Industrial Area, Phase – IV, Jigani Link Road,  Bommansandra, Bangalore - 560100, Karnataka

 

 

Country :

India

 

 

Financials (as on) :

31.03.2014

 

 

Date of Incorporation :

18.11.1993

 

 

Com. Reg. No.:

08-014937

 

 

Capital Investment / Paid-up Capital :

Rs. 280.688 Millions

 

 

CIN No.:

[Company Identification No.]

U51909KA1993PLC014937

 

 

TAN No.:

[Tax Deduction & Collection Account No.]

BLRS02580E

 

 

PAN No.:

[Permanent Account No.]

AABCS9936M

 

 

Legal Form :

A Closely Held Public Limited Liability Company

 

 

Line of Business :

Subject is engaged in providing contract research and manufacturing services in early stage drug discovery and development to pharmaceutical and biotechnology companies

 

 

No. of Employees :

Information Declined By The Management

 

 

RATING & COMMENTS

 

MIRA’s Rating :

A (65)

 

RATING

STATUS

PROPOSED CREDIT LINE

56-70

A

Financial & operational base are regarded healthy. General unfavorable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

Fairly Large

 

Maximum Credit Limit :

USD 92302000

 

 

Status :

Good

 

 

Payment Behaviour :

Regular

 

 

Litigation :

Clear

 

 

Comments :

Subject is a well-established company having fine track record.

 

The rating reflects company’s healthy financial risk profile marked by adequate liquidity position and decent profitability levels of the company.

 

Trade relations are reported as fair. Business is active. Payments are reported to be regular and as per commitment.

 

The company can be considered good for normal business dealings at usual trade terms and conditions.

 

NOTES:

Any query related to this report can be made on e-mail: infodept@mirainform.com while quoting report number, name and date.

 

ECGC Country Risk Classification List – June 1, 2014

 

Country Name

Previous Rating

(31.03.2014)

Current Rating

(01.06.2014)

India

A1

A1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

 

INDIAN ECONOMIC OVERVIEW

 

N E W S

 

Verdict Implications : Apex court order may alter coal import dynamics. Traders go slow on talks over coal supply contracts, uncertainty over cancellation of blocks weigh on stocks.

 

Recent arrest of the Chennai head of the Registrar of Companies, the ministry of corporate affairs arm that ensures that companies file all the information required by the Companies Act is the latest manifestation of a messy fight between a father and his adopted son for the control of Rs 40000 mn business empire. The Central Bureau of Investigation arrested Manumeethi Cholan after he accepted Rs 10 lakhs as bribe from M A M Ramaswamy, a CBI official said.

 

Central Bureau of Investigation books Electrotherm for cheating Central Bank of Rs 4360 mn.

 

Infosys maintains revenue guidance. COO Rao says attrition still an area of concern and it would take a few more quarters to bring down levels to 13-15 %.

 

DHL  to invest Euro 100 mn in India over next 2 years. The firm has chosen India to pilot its e-commerce business model for the Asia-Pacific region.

 

Blackstone may buy stake in BlueRidge SEZ in line with the fund’s real estate strategy in India.

 

Kingfisher Airlines Ltd grounded in October 2012 under the weight of heavy debt and accumulated losses, recently approached the Delhi high court for relief in two separate cases. The airline challenged a notice by Punjab & National Bank alleging that It had wilfully defaulted on Rs 7700 mn of loans and sought more time to comply with the requirements under the listing agreements with the Stock Exchanges.

 

OnMobile likely to sack another 300 employees. The lay-offs follow a spate of senior-level exits over the past two years, starting with of its founder. The overall lay-offs could number around 600 and are driven by the need to cut costs, says a former employee.

 

EXTERNAL AGENCY RATING

 

Rating Agency Name

CRISIL

Rating

Long Term Rating = AA-

Rating Explanation

High degree of safety and very low credit risk

Date

14.05.2014

 

Rating Agency Name

CRISIL

Rating

Short Term Rating = A1+

Rating Explanation

Very strong degree of safety and lowest credit risk

Date

14.05.2014

 

RBI DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available RBI Defaulters’ list.

 

EPF (Employee Provident Fund) DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available EPF (Employee Provident Fund) Defaulters’ list as of 31-03-2014.

 

INFORMATION DENIED

 

Management non co – operative (Tel No.: 91-80-28082808)

 

LOCATIONS

 

Registered /Corporate Office :

Biocon SEZ, Biocon Park, Plot No. 2/3, Bommansandra Industrial Area, Phase – IV, Jigani Link Road,  Bommansandra, Bangalore - 560100, Karnataka, India

Tel. No.:

91-80-28082808

Fax No.:

91-80-28083150

E-Mail :

dinesh.iyer@syngeneintl.com

suresh.reddy@syngeneintl.com

mayank.verma@syngeneintl.com

prateek.hiremath@syngeneintl.com

kiran.kumar@biocon.com

Website :

http://www.syngeneintl.com

Location :

Owned

 

 

Overseas Office :

876 Highlands Circle,  Los Altos, CA 94024 USA

Tel. No.:

1-609-638-8203

E-Mail :

bdc@syngeneintl.com

 

 

DIRECTORS

 

As on: 23.07.2014

 

Name :

Mr. Kiran Mazumdar Shaw

Designation :

Managing Director

Address :

Glenmore No. 58, Goolimanala Village, Sarjapur, Ho Bli Anekal Taluka, Bangalore-562106, Karnataka, India

Date of Birth/Age :

23.03.1953

Qualification :

B.Sc (Zoology) and PG in Malting and Brewing

Date of Appointment :

18.11.1993

DIN No.:

00347229

 

 

Name :

Mr. John Mccallum Marshall Shaw

Designation :

Director

Address :

Glenmore, Huskur Gate, Off 20th Km, Hosur Road, Electronic City P.O. Bangalore-562106, Karnataka, India

Date of Birth/Age :

12.04.1949

Qualification :

M.A. (Economics Honours)

Date of Appointment :

24.03.2000

DIN No.:

00347250

 

 

Name :

Peter John Bains

Designation :

Director

Address :

Hutchins Barn, Forty Green Road, Knotty Green, Beaconsfield, Bucks HP91XL, England

Date of Birth/Age :

26.07.1957

Qualification :

BSc Combined Hons. Physiology / Zoology, Sheffield University

Date of Appointment :

20.01.2010

DIN No.:

00430937

 

 

Name :

Charles Leland Cooney

Designation :

Director

Address :

35, Chestnut Place, Brookline, USA

Date of Birth/Age :

09.11.1944

Qualification :

Ph. D (Biochemical Engineering)

Date of Appointment :

19.01.2001

DIN No.:

01056607

 

 

Name :

Mr. John Russell Fotheringham Walls

Designation :

Director

Address :

40 IBIS Lane, Grove Park Chiswick, London W4UP, United Kingdom

Date of Birth/Age :

22.02.1944

Qualification :

Fellow Member of the Association of Chartered Certified Accountants, U.K

Date of Appointment :

27.04.2011

DIN No.:

03528496

 

 

Name :

Mr. Rosenberg Cather

Designation :

Director

Address :

565, Heming Way, Place Watherlooon N2T174, Canada

Date of Birth/Age :

23.05.1961

Date of Appointment :

08.08.2000

DIN No.:

06422834

 

 

Name :

Mr. Walls Russell

Designation :

Director

Address :

40, IBIS Lane, Grove Park, Chiswick, London W4UP, United Kingdom

Date of Birth/Age :

22.02.1944

Date of Appointment :

27.04.2011

 

 

Name :

Mr. Daniel M Bradbury

Designation :

Director      

Address :

5462, Soledad Road, La Jolla, California - 92037

Date of Birth/Age :

13.04.1961

Date of Appointment :

24.04.2013

DIN No.:

06599933

 

 

KEY EXECUTIVES

 

Name :

Mr. Mayank Verma

Designation :

Secretary

Address :

Indwins Glory Apartments, Flat No E3, Plot No. 5 1st Crossnal Wind, Tunnel Road, Murugeshpalaya, Bangalore – 560017, Karnataka, India

Date of Birth/Age :

03.02.1978

Date of Appointment :

01.08.2012

PAN No.:

AEPPV7701L

 

 

MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN

 

As on: 23.07.2014

 

Names of Shareholders

No. of Shares

Biocon Limited, India

47497525

Kiran Mazumdar Shaw

165

Arun Chandavarkar

165

Murli Krishnan K. N

165

Allegro Capital Private Limited, India

625000

Chinappa M B

1980

Syngene Employee Welfare Trust

1875000

GE Equity International, Mauritius

4166667

Total

54166667

 

Equity Share Break up (Percentage of Total Equity)

 

As on: 23.07.2014

 

Category

 

Percentage

 

 

 

Foreign holdings [Foreign institutional investors, Foreign Companies, Foreign Financial Institutions, Non-resident Indian or Overseas corporate bodies or others]

 

7.69

Bodies corporate

 

88.84

Other top fifty shareholders

 

3.47

 

 

 

Total

 

100.00

 

 

BUSINESS DETAILS

 

Line of Business :

Subject is engaged in providing contract research and manufacturing services in early stage drug discovery and development to pharmaceutical and biotechnology companies

 

 

Products :

ITC Code

Product Descriptions

99811121

Research and development services in chemistry and biology

 

 

Exports :

Not Divulged

 

 

Imports :

Not Divulged

 

 

GENERAL INFORMATION

 

Suppliers :

Not Divulged

 

 

Customers :

Not Divulged

 

 

No. of Employees :

Information Declined By The Management

 

 

Bankers :

·         The Bank of Nova Scotia, S N Towers, 25/2, M G Road, Bangalore – 560001, Karnataka, India

·         The Hongkong and Shanghai Banking Corporation Limited, 7 Mahatma Gandhi Road, Bangalore – 560001, Karnataka, India

 

 

Facilities :

 

Secured Loan

As on

31.03.2014

As on

31.03.2013

 

(Rs. In Millions)

SHORT TERM BORROWINGS:

 

 

Foreign currency term loans from others

902.000

0.000

Other loans and advances

46.000

0.000

Total

948.000

0.000

 

 

 

Banking Relations :

--

 

 

Auditors :

 

Name :

S.R. Batliboi and Associates

Chartered Accountants

Address :

U B City, Canberra Block, 12th and 13th Floor No 24, Vittal Malya Road, Bangalore – 560001, Karnataka, India

Tel. No.:

91-80-40275000

Fax No.:

91-80-22106000

PAN No.:

AABFS3421N

 

 

Holding company :

Biocon Limited [L24234KA1978PLC003417]

 

 

Fellow Subsidiary company :

·         Biocon Research Limited [U73100KA2008PLC046583]

·         Biocon SA

 

 

Subsidiaries :

Clinigene International Limited [U85195KA2000PLC027566]

 

 

CAPITAL STRUCTURE

 

As on: 23.07.2014

 

Authorized Capital: Rs.300.000 Millions 

 

Issued, Subscribed & Paid-up Capital: Rs. 280.688 Millions

 

As on: 31.03.2014

 

Authorized Capital:

No. of Shares

Type

Value

Amount

 

 

 

 

60000000

Equity Shares

Rs.5/- each

Rs. 300.000 Millions

 

 

 

 

 


Issued, Subscribed & Paid-up Capital:

No. of Shares

Type

Value

Amount

 

 

 

 

54166667

Equity Shares

Rs.5/- each

Rs. 271.000 Millions

 

Less: Unpaid shares

 

Rs. 10.000 Millions

 

Total

 

Rs. 261.000 Millions

 

 

 


 

FINANCIAL DATA

[All figures are in Rupees Millions]

 

ABRIDGED BALANCE SHEET

 

SOURCES OF FUNDS

 

31.03.2014

31.03.2013

31.03.2012

I.              EQUITY AND LIABILITIES

 

 

 

(1)Shareholders' Funds

 

 

 

(a) Share Capital

261.000

261.000

241.000

(b) Reserves & Surplus

6332.000

4934.000

2781.000

(c) Money received against share warrants

0.000

0.000

0.000

 

 

 

 

(2) Share Application money pending allotment

0.000

0.000

0.000

Total Shareholders’ Funds (1) + (2)

6593.000

5195.000

3022.000

 

 

 

 

(3) Non-Current Liabilities

 

 

 

(a) long-term borrowings

0.000

0.000

42.000

(b) Deferred tax liabilities (Net)

51.000

65.000

82.000

(c) Other long term liabilities

583.000

464.000

554.000

(d) long-term provisions

58.000

28.000

12.000

Total Non-current Liabilities (3)

692.000

557.000

690.000

 

 

 

 

(4) Current Liabilities

 

 

 

(a) Short term borrowings

1549.000

0.000

926.000

(b) Trade payables

766.000

827.000

644.000

(c) Other current liabilities

2212.000

575.000

566.000

(d) Short-term provisions

97.000

88.000

67.000

Total Current Liabilities (4)

4624.000

1490.000

2203.000

 

 

 

 

TOTAL

11909.000

7242.000

5915.000

 

 

 

 

II.            ASSETS

 

 

 

(1) Non-current assets

 

 

 

(a) Fixed Assets

 

 

 

(i) Tangible assets

3941.000

3810.000

3830.000

(ii) Intangible Assets

0.000

0.000

0.000

(iii) Capital work-in-progress

453.000

88.000

108.000

(iv) Intangible assets under development

0.000

0.000

0.000

(b) Non-current Investments

1.000

1.000

1.000

(c) Deferred tax assets (net)

0.000

0.000

0.000

(d) Long-term Loan and Advances

1031.000

863.000

497.000

(e) Other Non-current assets

143.000

110.000

51.000

Total Non-Current Assets

5569.000

4872.000

4487.000

 

 

 

 

(2) Current assets

 

 

 

(a) Current investments

3520.000

691.000

0.000

(b) Inventories

149.000

179.000

198.000

(c) Trade receivables

943.000

766.000

434.000

(d) Cash and cash equivalents

916.000

118.000

377.000

(e) Short-term loans and advances

269.000

160.000

74.000

(f) Other current assets

543.000

456.000

345.000

Total Current Assets

6340.000

2370.000

1428.000

 

 

 

 

TOTAL

11909.000

7242.000

5915.000

 

PROFIT & LOSS ACCOUNT

 

 

PARTICULARS

31.03.2014

31.03.2013

31.03.2012

 

SALES

 

 

 

 

 

Income

6995.000

5500.000

4167.000

 

 

Other Income

82.000

42.000

15.000

 

 

TOTAL                                     (A)

7077.000

5542.000

4182.000

 

 

 

 

 

Less

EXPENSES

 

 

 

 

 

Cost of Materials Consumed

1898.000

1534.000

1134.000

 

 

Purchases of Stock-in-Trade

0.000

0.000

0.000

 

 

Changes in inventories of finished goods, work-in-progress and Stock-in-Trade

16.000

(33.000)

(23.000)

 

 

Employees benefits expense

1556.000

1235.000

984.000

 

 

Other expenses

1390.000

1124.000

683.000

 

 

TOTAL                                     (B)

4860.000

3860.000

2778.000

 

 

 

 

 

Less

PROFIT BEFORE INTEREST, TAX, DEPRECIATION AND AMORTISATION (A-B)     (C)

2217.000

1682.000

1404.000

 

 

 

 

 

Less

FINANCIAL EXPENSES                                    (D)

4.000

65.000

103.000

 

 

 

 

 

 

PROFIT BEFORE TAX, DEPRECIATION AND AMORTISATION (C-D)                                       (E)

2213.000

1617.000

1301.000

 

 

 

 

 

Less/ Add

DEPRECIATION/ AMORTISATION                     (F)

656.000

599.000

547.000

 

 

 

 

 

 

PROFIT BEFORE TAX (E-F)                              (G)

1557.000

1018.000

754.000

 

 

 

 

 

Less

TAX                                                                  (H)

218.000

42.000

27.000

 

 

 

 

 

 

PROFIT AFTER TAX (G-H)                                (I)

1339.000

976.000

727.000

 

 

 

 

 

Add

PREVIOUS YEARS’ BALANCE BROUGHT FORWARD

3664.000

2688.000

1961.000

 

 

 

 

 

 

BALANCE CARRIED TO THE B/S

5003.000

3664.000

2688.000

 

 

 

 

 

 

EARNINGS IN FOREIGN CURRENCY

 

 

 

 

 

Export Earnings

6848.000

5315.000

3918.000

 

 

 

 

 

 

Earnings Per Share (Rs.)

25.60

20.09

15.29

 

KEY RATIOS

 

PARTICULARS

 

 

31.03.2014

31.03.2013

31.03.2012

PAT / Total Income

(%)

18.92

17.61

17.38

 

 

 

 

 

Net Profit Margin

(PBT/Sales)

(%)

22.26

18.51

18.09

 

 

 

 

 

Return on Total Assets

(PBT/Total Assets}

(%)

13.59

14.23

12.99

 

 

 

 

 

Return on Investment (ROI)

(PBT/Networth)

 

0.24

0.20

0.25

 

 

 

 

 

Debt Equity Ratio

(Total Debt/Networth)

 

0.23

0.00

0.32

 

 

 

 

 

Current Ratio

(Current Asset/Current Liability)

 

1.37

1.59

0.65

 

 

FINANCIAL ANALYSIS

[All figures are in Rupees Millions]

 

DEBT EQUITY RATIO

 

Particular

31.03.2012

31.03.2013

31.03.2014

 

(Rs. In Millions)

(Rs. In Millions)

(Rs. In Millions)

Share Capital

241.000

261.000

261.000

Reserves & Surplus

2781.000

4934.000

6332.000

Net worth

3022.000

5195.000

6593.000

 

 

 

 

long-term borrowings

42.000

0.000

0.000

Short term borrowings

926.000

0.000

1549.000

Total borrowings

968.000

0.000

1549.000

Debt/Equity ratio

0.320

0.000

0.235

 

 

YEAR-ON-YEAR GROWTH

 

Year on Year Growth

31.03.2012

31.03.2013

31.03.2014

 

(Rs. In Millions)

(Rs. In Millions)

(Rs. In Millions)

Sales

4167.000

5500.000

6995.000

 

 

31.989

27.182

 


NET PROFIT MARGIN

 

Net Profit Margin

31.03.2012

31.03.2013

31.03.2014

 

(Rs. In Millions)

(Rs. In Millions)

(Rs. In Millions)

Sales

4167.000

5500.000

6995.000

Profit

727.000

976.000

1339.000

 

17.45%

17.75%

19.14%

 

 

 

 

LOCAL AGENCY FURTHER INFORMATION

 

Sr. No.

Check List by Info Agents

Available in Report (Yes / No)

1]

Year of Establishment

Yes

2]

Locality of the firm

Yes

3]

Constitutions of the firm

Yes

4]

Premises details

No

5]

Type of Business

Yes

6]

Line of Business

Yes

7]

Promoter's background

Yes

8]

No. of employees

No 

9]

Name of person contacted

Yes

10]

Designation of contact person

Yes

11]

Turnover of firm for last three years

Yes

12]

Profitability for last three years

Yes

13]

Reasons for variation <> 20%

--

14]

Estimation for coming financial year

No

15]

Capital in the business

Yes

16]

Details of sister concerns

Yes

17]

Major suppliers

No

18]

Major customers

No

19]

Payments terms

No

20]

Export / Import details (if applicable)

No

21]

Market information

--

22]

Litigations that the firm / promoter involved in

--

23]

Banking Details

Yes

24]

Banking facility details

Yes

25]

Conduct of the banking account

--

26]

Buyer visit details

--

27]

Financials, if provided

Yes

28]

Incorporation details, if applicable

Yes

29]

Last accounts filed at ROC

Yes

30]

Major Shareholders, if available

Yes

31]

Date of Birth of Proprietor/Partner/Director, if available

Yes

32]

PAN of Proprietor/Partner/Director, if available

No

33]

Voter ID No of Proprietor/Partner/Director, if available

No

34]

External Agency Rating, if available

Yes

 

UNSECURED LOAN

 

Particulars

As on

31.03.2014

As on

31.03.2013

 

(Rs. In Millions)

SHORT TERM BORROWINGS:

 

 

Foreign currency term loans from others

601.000

0.000

Total

601.000

0.000

 

 

PERFORMANCE ANALYSIS

 

For the Financial Year 2013-14, the Company registered a strong growth of 28% in revenues from Rs. 5542 millions to Rs. 7077 millions. The Operational Margin (EBITDA) increased from Rs. 1682 millions to Rs. 2217 millions representing a 32% increase during the year. The Company Profit after Tax also increased from Rs. 976 millions to Rs. 1339 millions for the year. The significant increase in profitability is primarily attributed improved utilization of existing capacities and moving up the value chain with differential models and more integrated service offerings.

 


INDEX OF CHARGES:

 

S.No.

Charge ID

Date of Charge Creation/Modification

Charge amount secured

Charge Holder

Address

Service Request Number (SRN)

1

10274310

26/04/2012 *

500,000,000.00

THE BANK OF NOVA SCOTIA

S N TOWERS,, 25/2, M G ROAD,, BANGALORE, KARNATAKA - 560001, INDIA

B38730297

2

10101396

25/09/2008 *

500,000,000.00

ABN AMRO BANK N. V.

7TH FLOOR, SAKHAR BHAVAN,, NARIMAN POINT,, MUMBAI, MAHARASHTRA - 400021, INDIA

A50085257

3

10108590

28/02/2008

800,000,000.00

STATE BANK OF INDIA

OVERSEAS BRANCH, ST MARKS ROAD LHO COMPOUND, BANGALORE, KARNATAKA - 560001, INDIA

A40684789

4

90196794

17/05/1995 *

350,000.00

ICICI BANKING CORPORATION LTD

BANGALORE, BANGALORE, KARNATAKA, INDIA

-

5

90196748

20/08/2010 *

1,636,500,000.00

THE HONGKONG AND SHANGHAI BANKING CORPORATION LIMI 
TED

7 M.G.ROAD, BANGALORE, KARNATAKA - 560001, INDIA

A92067305

 

 


CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgment or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration:

No exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration:

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime:

            Charges or conviction registered against subject:                                                                       None

 

5]         Records on Violation of Anti-Corruption Laws:

            Charges or investigation registered against subject:                                                        None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards:

            Charges or investigation registered against subject:                                                        None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government:

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package:

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report:

            No press reports / filings exists on the subject.

 


 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.61.23

UK Pound

1

Rs.98.53

Euro

1

Rs.77.75

 

 

INFORMATION DETAILS

 

Information Gathered by :

NYA

 

 

Analysis Done by :

KAR

 

 

Report Prepared by :

JAY

 


 

SCORE & RATING EXPLANATIONS

 

SCORE FACTORS

 

RANGE

POINTS

HISTORY

1~10

8

PAID-UP CAPITAL

1~10

7

OPERATING SCALE

1~10

7

FINANCIAL CONDITION

 

 

--BUSINESS SCALE

1~10

7

--PROFITABILIRY

1~10

8

--LIQUIDITY

1~10

7

--LEVERAGE

1~10

7

--RESERVES

1~10

7

--CREDIT LINES

1~10

7

--MARGINS

-5~5

--

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

YES

--LITIGATION

YES/NO

NO

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

NO

--AFFILIATION

YES/NO

YES

--LISTED

YES/NO

NO

--OTHER MERIT FACTORS

YES/NO

YES

DEFAULTER

 

 

--RBI

YES/NO

NO

--EPF

YES/NO

NO

TOTAL

 

65

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                  Payment record (10%)

Credit history (10%)                   Market trend (10%)                                Operational size (10%)

 


 

RATING EXPLANATIONS

 

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

--

NB

                                       New Business

 

--

 

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.